Videos

Perspective on how the anticoagulant could progress to human trials and potentially, marketing use for coronavirus prevention.

A discussion with an RPI investigator after promising early findings.

A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.

West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.

A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.

A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.

Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.

In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.

Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.

In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.

How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.

Gilead provides some important information on this investigational therapy.

A study looking at PrEP population obstacles shows men who have sex with men are more likely to not seek out information nor access to prophylaxis.

Dr. Marc Pitasi, epidemiologist, discusses facilitators of routine HIV screening among primary care physicians.

A discussion around new data presented at AIDS 2020 which shows statewide strategies are breaking down barriers.

Uncovering interesting findings regarding patients' PrEP regimen.

How much does the current virus crisis share in common with early HIV outbreak scare?

With fostemsavir now available for patients with few options, an expert discusses what challenges MDR-HIV patients face in their care.

A look at the BRIGHTE study data which evidenced the recently FDA-approved add-on agent.

Carey Hwang, MD, PhD, executive director and product development lead, Global Clinical Development of Infectious Disease at Merck spoke with Contagion® regarding the therapies and went further into depth about the studies.

How the inflammatory-based syndrome is affecting US children during the COVID-19 pandemic.

A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.

A discussion with a Yale expert on what new CDC data shows.

Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.

A brief overview of our top stories.

Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.

Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?

Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.